Orbimed Advisors LLC
Director at ADARx Pharmaceuticals · 60 reported transactions in 16 companies · latest trade Sep 28, 2026
Their record
Across their whole record, 2 purchases can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +302.4%, S&P 500 +6.3% over the same days.
Their trades
Bought | Sep 28, 2026 | Sep 28, 2026 close $20.09 → Oct 28, 2026 close $17.95. S&P 500 +0.5% over the same days. | ||
Bought | Sep 28, 2026 | Sep 28, 2026 close $20.09 → Oct 28, 2026 close $17.95. S&P 500 +0.5% over the same days. | ||
Bought | Sep 28, 2026 | Sep 28, 2026 close $20.09 → Oct 28, 2026 close $17.95. S&P 500 +0.5% over the same days. |
BoughtADARx Pharmaceuticals
$10M
Sep 28, 2026 close $20.09 → Oct 28, 2026 close $17.95. S&P 500 +0.5% over the same days.
BoughtADARx Pharmaceuticals
$1.05M
Sep 28, 2026 close $20.09 → Oct 28, 2026 close $17.95. S&P 500 +0.5% over the same days.
BoughtADARx Pharmaceuticals
$5.1M
Sep 28, 2026 close $20.09 → Oct 28, 2026 close $17.95. S&P 500 +0.5% over the same days.